{
    "paper_id": "PMC7134578",
    "metadata": {
        "title": "Upheaval in cancer care during the COVID-19 outbreak",
        "authors": [
            {
                "first": "Omolola",
                "middle": [],
                "last": "Salako",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Kehinde",
                "middle": [],
                "last": "Okunade",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Matthew",
                "middle": [],
                "last": "Allsop",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Muhammedu",
                "middle": [],
                "last": "Habeebu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mariam",
                "middle": [],
                "last": "Toye",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Glory",
                "middle": [],
                "last": "Oluyede",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Gabriel",
                "middle": [],
                "last": "Fagbenro",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Babatunde",
                "middle": [],
                "last": "Salako",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "\u201cThe way we treat cancer over the next few months will change enormously\u2026\u201d writes a British Oncologist. \u201c\u2026It is highly probable that the cancer mortality and morbidity will rise, not because of the coronavirus pandemic, but because we are not able to treat cancers as we should normally [1].",
            "cite_spans": [
                {
                    "start": 288,
                    "end": 289,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "In these uncertain times, we are having to make necessary adjustments to social distancing, large religious, academic and social activities are being shut down, with law enforcement agencies stationed in strategic places to ensure people do not gather as usual. A recent early morning drive on commercial routes and the ever congested Third Mainland Bridge and Ikorodu Road in Lagos state is smooth with low noise pollution and unusually free roads. The agile street entrepreneurs are present but look frustrated because they are unable to sell their wares and products, as there is neither traffic nor the consequent abundance of customers.",
            "cite_spans": [],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "Novel Coronavirus, or COVID-19 infection, entered mainstream consciousness in December 2019 via the media when it first broke out in Wuhan, China. It is now becoming a stark global force for many, dominating political decision-making that has direct implications for our liberty. COVID-19 has disrupted economic activities around the globe such as trading and shipping and has ushered in a wave of scarcity and panic buying of essential products [2].",
            "cite_spans": [
                {
                    "start": 447,
                    "end": 448,
                    "mention": "2",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "There are other problems including reduced sales revenue, pay cuts and job losses, and disruption of health care services. This is a global reality and Lagos state, the commercial hub of the country, has recorded 30 positive cases (at the time of writing) and discharged home two cases after they had received weeks of care whilst at a government-approved isolation centre in the State [3]. However, there is a strong possibility that there are undetected and asymptomatic cases; hence we may see a significant rise in the coming weeks. As expected, people with ill health will present to clinics and emergency wards, and health care workers will continue to be at the frontline of this pandemic whilst being at increased risk of exposure to the virus.",
            "cite_spans": [
                {
                    "start": 387,
                    "end": 388,
                    "mention": "3",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "To control the transmission of coronavirus infection many clinical activities have been reduced. Suspicious COVID-19 cases are being identified, following a risk-assessment [4] while confirmed cases are referred or directly picked up for government- supervised isolation in approved facilities, by the Nigeria Centre for Disease Control (NCDC), autopsies are being deferred and some health care workers with a history of contact or exposure are now placed on home supervised self-quarantine.",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 175,
                    "mention": "4",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "Many ill patients too, with conditions including diabetes, cancer, and infectious diseases may be stranded at home or stuck on the wards of health facilities. Several clinical, social, academic and religious activities have ground to a halt. For those living with cancer, the diseases will continue to grow in the absence of treatment, therefore cancer may spread, develop resistance to treatments, cause multiple complications or, in some instances, death.",
            "cite_spans": [],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "Reports from a nationwide study in China by Wenhua Liang stated that 18 participants out of 1,590 COVID-19 cases had a cancer history [5]. This group of patients, though small, recorded severe adverse events such as admission to the intensive care unit for invasive ventilation or death. These adverse events were most common in patients who had received chemotherapy or surgery within the last month. This study reported that a cancer history represented the highest risk for severe events especially in the elderly age group and clinical deterioration was rapid in this group.",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 136,
                    "mention": "5",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "The first COVID-19 death has been recorded in Nigeria. It was that of a 67-year-old man with a history of diabetes mellitus and multiple myeloma, a type of blood cancer. He was undergoing chemotherapy and he had just returned to Nigeria following medical treatment in the United Kingdom [6].",
            "cite_spans": [
                {
                    "start": 288,
                    "end": 289,
                    "mention": "6",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "Our priority at this time should be to intensify public education amongst cancer patients and limit their risk of being infected as they fall into a vulnerable group.",
            "cite_spans": [],
            "section": "Upheaval in cancer care during the COVID-19 outbreak in Nigeria",
            "ref_spans": []
        },
        {
            "text": "There is no doubt that the delivery of cancer care will be disrupted. Cancer clinics may need to reduce clinical appointments, chemotherapy administration encounters, alter radiotherapy schedules, and cancel or postpone elective cancer surgeries. There may be a shortage of supplies, non-availability of drugs and consumables. Newly diagnosed and existing patients with cancer who experience chest symptoms (e.g. breathlessness) due to lung metastases may be denied care due to heightened suspicion of COVID-19 infection. For patients with cancer, these will have huge repercussions on their experience and management of cancer-related symptoms, quality of life and survival.",
            "cite_spans": [],
            "section": "Effects of COVID-19 on cancer treatment",
            "ref_spans": []
        },
        {
            "text": "According to the American Society of Clinical Oncology(ASCO), \u201cThere is no direct evidence to support changes in cancer regimen during the pandemic\u201d [7]. Therefore, routinely stopping anticancer or immunosuppressive therapy is not recommended. There are currently cancellations or postponement of elective cancer surgeries and in the coming days radiotherapy appointments may also be affected. Community-based palliative treatment of advanced cancers will also be affected significantly as health care workers are minimising their contacts through social distancing and due to the increase in demand for their expertise in the treatment of confirmed cases in the health facilities. Thus, there is a grave impact on disease control.",
            "cite_spans": [
                {
                    "start": 150,
                    "end": 151,
                    "mention": "7",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Effects of COVID-19 on cancer treatment",
            "ref_spans": []
        },
        {
            "text": "For us oncology professionals working in low-resource settings, we are faced with the dilemma of striking a balance between protecting ourselves and giving our patients a good chance to fight their cancers during the COVID-19 outbreak. We must tread with caution, as we are a critical workforce, highly trained and skilled in treating cancer, as well as being an endangered specialty with a limited human resource pool in the country. This is not the time to be careless in the frontline as we are all at risk and we must do all that is required to reduce our chances of getting infected. The World Health Organization\u2019s recommendation for health care providers in this COVID-19 era is well articulated in an online resource [8].",
            "cite_spans": [
                {
                    "start": 726,
                    "end": 727,
                    "mention": "8",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Effects of COVID-19 on cancer treatment",
            "ref_spans": []
        },
        {
            "text": "Palliation is an ethical obligation and we should strive for good symptom control and comfort care for cancer patients in a pandemic [11]. To support palliative and supportive care of people with cancer, these proposed four areas (4S) for palliating a pandemic [11] can be used to guide a response but need to be adapted and considered in the context of the availability of resources and expertise in the context of low-resource settings:\n\u201cStuff\u201d (i.e. stockpile of medications, equipment to deliver medications)\u201cStaff\u201d (identifying and consulting with clinicians with palliative care expertise, deliver focused education sessions to frontline staff for symptom management and supporting end-of-life care for patients with COVID-19)\u201cSpace\u201d (e.g. identify wards and nonclinical areas in all health care facilities that would be appropriate to accommodate large numbers of patients expected to die)\u201cSystems\u201d (e.g. develop systems for direct consultation of palliative care expertise for staff in hospitals, create a triage system to identify patients with cancer in need of specialist palliative care management)",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 136,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 262,
                    "end": 264,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Palliative cancer care during the COVID-19 outbreak ::: How do we respond?",
            "ref_spans": []
        },
        {
            "text": "Bereavement needs to be considered in the context of COVID-19 too. Globally we are seeing increasing numbers of unexpected and premature deaths from COVID-19. Families will need support with bereavement where they may have been expecting a longer trajectory of illness for a loved one with cancer. Furthermore, traditional cultural rituals and ceremonies may be prohibited in line with social distancing. We need talk to spiritual leaders to understand what can occur and provide guidance to the families of those who die to discuss how and when they might be able to hold services for their loved ones.",
            "cite_spans": [],
            "section": "Palliative cancer care during the COVID-19 outbreak ::: How do we respond?",
            "ref_spans": []
        },
        {
            "text": "A time like this is a true test of leadership and our values. As leaders we must make clinical and economical decisions in line with the ethical rationing of resources and the global call to flatten the curve of the infection.",
            "cite_spans": [],
            "section": "Palliative cancer care during the COVID-19 outbreak ::: How do we respond?",
            "ref_spans": []
        },
        {
            "text": "To control the transmission of coronavirus infection many clinical activities have been reduced in most countries, including Nigeria. For people living with cancer, the diseases will continue to grow in the absence of treatment, therefore cancer may spread, develop resistance to treatments, cause multiple complications or, in some instances, death. To respond to this important area of critical need, government must constitute a multidisciplinary oncology and infectious disease team to create, review and rapidly update a clinical policy for combating COVID-19 infection during cancer care, strategise to reduce clinic visits and accelerate remote online care, empower patients and caregivers through communication using digital technology interventions and leverage on existing digital health platforms in the country. In addition, efforts should be made to support palliative and supportive care of people with advanced cancer during the outbreak by systematically identifying critical areas for consideration and development in the context of the availability of resources and expertise in resource-constrained settings such as Nigeria.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "The authors declare that they have no funding for this article.",
            "cite_spans": [],
            "section": "Funding statement",
            "ref_spans": []
        },
        {
            "text": "The authors declare that they have no conflicts of interest regarding this work.",
            "cite_spans": [],
            "section": "Conflicts of interest",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Coronavirus means difficult, life-changing decisions for me and my cancer patients",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gossage",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Guardian",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Advice for public",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Palliating a pandemic: \u201call patients must be cared for\u201d",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Downar",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Seccareccia",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Pain Symptom Manag",
            "volume": "39",
            "issn": "2",
            "pages": "291-295",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Coronavirus and macroeconomic policy",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Fornaro",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wolf",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Coronavirus Update (Live): 350,440 Cases and 15,315 Deaths from COVID-19 Virus Outbreak\u2014Worldometer",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Coronavirus disease 2019 (COVID-19) risk assessment and public health management decision making",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Oncol",
            "volume": "21",
            "issn": "3",
            "pages": "335-337",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "First Recorded COVID-19 death in Nigeria",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Disruptions in Cancer Care in the Era of COVID-19",
            "authors": [],
            "year": null,
            "venue": "Medscape",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Coronavirus disease (COVID-19) Outbreak: Rights, roles and responsibilities of health workers, including key considerations for occupational safety and health",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "How Is Oncology Adapting to COVID-19?",
            "authors": [],
            "year": null,
            "venue": "Medscape",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}